JP2001511677A - Bone graft - Google Patents

Bone graft

Info

Publication number
JP2001511677A
JP2001511677A JP53567198A JP53567198A JP2001511677A JP 2001511677 A JP2001511677 A JP 2001511677A JP 53567198 A JP53567198 A JP 53567198A JP 53567198 A JP53567198 A JP 53567198A JP 2001511677 A JP2001511677 A JP 2001511677A
Authority
JP
Japan
Prior art keywords
implant
bone
tissue
cells
essentially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53567198A
Other languages
Japanese (ja)
Inventor
レンベルト,ステファン
Original Assignee
マイグラータ ユーケイ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイグラータ ユーケイ リミテッド filed Critical マイグラータ ユーケイ リミテッド
Publication of JP2001511677A publication Critical patent/JP2001511677A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2846Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00395Coating or prosthesis-covering structure made of metals or of alloys
    • A61F2310/00407Coating made of titanium or of Ti-based alloys

Abstract

(57)【要約】 本発明は、誘導又は制御された骨組織再生のための移植組織に関する。その移植組織は、本質的に三次元的材料で、骨細胞をそれに付着させるか、又はそれら細胞をそれに付着させるように変性することができ、細胞を一つより多くの層として成長させることができる形態をしている三次元的材料からなる。本発明によれば、その材料は、本質的に生体適合性繊維材料からなる。   (57) [Summary] The present invention relates to implants for guided or controlled bone tissue regeneration. The implant is essentially a three-dimensional material that can attach bone cells to it or can be modified to attach them to it, allowing the cells to grow in more than one layer. It consists of a three-dimensional material in a possible form. According to the invention, the material consists essentially of a biocompatible fiber material.

Description

【発明の詳細な説明】 骨移植組織 本発明は、誘導(guided)又は制御された(controlled)骨組織再生のための移植 組織に関する。 誘導組織再生は、実際の歯に新しい歯周アタッチメント(attachment)を作るた めの既知の技術である。この技術は、顎の細胞型のあるものだけが支持組織の形 成に肯定的な効果を有するのに対し、他の組織は否定的な効果を有すると言う仮 定に基づいている。後者、即ち上皮、結合組織及び骨細胞は、歯に到達しないよ うにすべきであり、それに対し前者は殆ど歯周靭帯から歯へ自由に到達できるよ うにすべきである。望ましくない細胞を離しておくため、歯の近くに配置した「 セルタイト(cell-tight)」フィルタ又は膜を用いる。柔らかいその膜は、歯に適 用されるか又は歯に付着する。よく使われる膜は延伸PTFEからなり、ゴアー (GORE)歯周膜の商標名で販売されている〔ゴットロー(Gottlow)等、J.Clin.Pe riodontology 1984;9:494-503、ポントリーロ(Pontoriero)R.等、J.Clin.Per iodontology 1988;15:247-254、ポントリーロR.等、J.Clin.Periodontology 1989;16:170-174、ゴットローJ.等、1986;13:604-616、ベッカー(Becker)W.等 、Int.G.Periodont.Rest.Dent.1988;3:2-16〕。 この技術は、修正すれば、固定具に関連して有用であると言われている。平ら な膜をその固定具の上、組織弁(flap)の下に適用する〔ダーリン(Dahlin)等、In t.J.Oral Maxillofac.Implants 1989;4(1):19-25、ベッカーW.等、Int.J. Periodont.Rest.Dent.1990;10:93-102〕。しかし、この技術は骨組織の満足 すべき再生を与えないことが判明している。 特許公報、PCT/SE91/00216に記載されているように、軟かいセ ルタイト(cell-tight)膜は、固定具に連続して骨組織を再生させる、即ち、周り の骨レベルから(上に)冠状に再生させるのには不適切であることが判明してい る。その代わり、以前は骨組織の再生に不利であると考えられていた顎の細胞は 、この方法では実際に極めて有利であることが判明した。従って、骨膜及び骨端 部 から骨細胞が固定具の周りの手術領域に到達できるようにすべきである。この到 達性は、この特許刊行物による装置の堅固さ及び孔によって生じさせ得る。 この技術は、The International Journal of Oral and Maxillofacial Implan ts(1995年)第10巻、No.1のS.ジョバノビック(Jovanovic)等による 文献にも記載されている。この文献によれば、犬のモデルで膜埋め込み治療によ り冠状骨形成が例示されている。骨の形成は、チタンを用いた補強e−PTFE 膜を用いることにより得られている。これらの膜は研究中最初の形態を維持し、 凝血塊安定化のための大きな空間を与え、標準的膜を用いた場合に比較して一層 多くの骨を与える結果になつた。 今度、ジョバノビック等による文献によって用いられた網を、繊維材料、好ま しくはウールの形の繊維材料で置き換えると、充分堅く、空間を与える能力が得 られることが判明した。 WO 9007308号公報には、繊維材料の形になっていてもよい障壁が記 載されている。この障壁は骨支持組織の再生を目的としたものであり、第一に歯 周靭帯組織、第二に周囲の歯槽骨組織、第三に歯肉結合組織及び上皮の再生を含 めた予測可能な治癒結果を与えると言われている。例えば、隆起を含めた分離手 段と組合せて障壁を用いることが必須である。更に、その障壁は生物分解性材料 からなることが推奨されている。 異なった細胞の特別な治癒結果を与えるこの既知の材料とは対照的に、本発明 による繊維材料は、主に又は本質的に手術介在領域中の骨細胞だけの誘導又は制 御された再生又は成長のための移植組織として用いることを目的としている。特 許WO 9007308公報によれば必要になる種類の分離手段は、不必要であ る。更に、本発明によれば、骨細胞の誘導成長又は再生は、移植組織の形及び材 料によって決定され、治療されるべき損傷に依存する。実際上、移植組織の形は 、手術を行う人によって決定される。 本発明による新規な移植組織は、三次元的空間を形成する多孔質の生体適合性 非生物分解性(non-biodegradable,細菌分解性でない)材料からなる本質的になり 、その材料は骨細胞をそれに付着させるか、又はそれら細胞をそれに付着させる ように変性することができ、細胞を三次元的に成長させることができる形態をし て いる。この材料は繊維状で、好ましくはウールの形をしていることが必須である 。特に好ましい形態は、ウール、糸又はパッドであり、それらは外科医により希 望の形に合わせて容易に作ることができる。 本発明による新規な材料は、それが挿入される体の領域中に行き亙っている圧 力に耐える充分強さを有し、適当な気孔率も有すべきである。 繊維の実際の直径は、体の部位及び必要な強度に依存して変化する。通常この 直径は1mmより小さく、好ましくは0.5mmより小さく、最も好ましくは0 .1mmより小さい。 気孔率に関し、気孔率が大きい程、その移植組織の空間内に形成される骨細胞 は多くなることは明らかである。しかし、気孔率を余り大きくすると、隣接組織 によって及ぼされる圧力に耐える移植組織の能力は低下する。一方、新しく生じ た骨の中に削孔操作を、例えばネジを固定するため、行わなければならない場合 、気孔率を余り低くしてはならない。従って、最適気孔率は、繊維材料が使用さ れる場所に依存し、当業者によって容易に決定することができる。 新規な生体適合性移植組織は、チタン又はチタン被覆繊維からなるのが好まし い。それら繊維はチタンウールの形をしているのが好ましい。他の種類の材料は セラミック材料である。更に、新規な材料は、糸又はパッドの形で与えることが でき、それらは場合により粘膜を通って繊維が図らずも侵入するのを避けるため 、例えば、ポリ乳酸のフィルム又は膜により少なくとも部分的に被覆してもよい 。 PCT/SE91/00216公報及びジャバノビック等による上記文献から 知られている器具(device)と比較して、本発明による器具は幾つかの利点を与え る。即ち、新規な器具は殆どどのような形にしてでも得ることができ、多かれ少 なかれ目的用途に合せて作ることができる。新しく形成された骨細胞が表面上に 盛り上がる傾向を持つことが証明されているように、新規材料は、速い骨再生の ための増大した表面を与え、それによって骨細胞の増殖を増大する。他の利点は 、高価な製造設備を必要とすることなく、その器具を作ることができることであ る。他の利点は、骨形態蛋白質(BMP)を本発明による繊維に結合することが できることに関する。 新規な器具は、最初の形態を失った骨格部分を置き換える問題が存在する歯補 綴以外の領域でも有用である。交通事故後、顔の潰れた又は凹んだ骨格部分は修 復しなければならず、骨新生治療では、時々置換する必要がある骨格部分を外科 的に除去する必要がある。 移植組織を用いた方法を次に記載する。 移植組織を植入すべき領域を、先ず一つか二つの別々の粘膜骨膜弁を持ち上げ ることにより露出させる。骨組織中に微細な孔(直径0.5〜1mm)をあけ、 緻密な骨の壁に孔をあけ、傷ついた領域中への出血を促進するようにする。この 技師により、再生すべき領域中の骨再生過程を改善する。外科医によりその領域 を調べ、適切な移植組織の大きさを選択する。然る後、移植組織をその欠陥形態 に適合するようにトリミングする。もし必要ならば、その移植組織を骨に固定す る。例えば、小さなネジでこれを異なったやり方で行うことができる。軟質組織 をトリミングし、移植組織の上に、これが弁により完全に覆われるように置く。 弁を縫合し、その領域を放置して治療する。治療段階中、その領域を外部からの 力に対し保護すべきである。このことは、もしその移植片が口の中に用いられた ならば、治療段階中、取り外し可能な義歯は付けない方が良いことを意味する。DETAILED DESCRIPTION OF THE INVENTION Bone Graft The present invention relates to a graft for guided or controlled bone regeneration. Guided tissue regeneration is a known technique for making new periodontal attachments to actual teeth. This technique is based on the assumption that only some of the jaw cell types have a positive effect on the formation of supporting tissue, while others have a negative effect. The latter, ie, epithelium, connective tissue and bone cells, should not reach the teeth, whereas the former should allow almost free access to the teeth from the periodontal ligament. A "cell-tight" filter or membrane placed near the teeth is used to keep unwanted cells apart. The soft film is applied to or adheres to the teeth. A commonly used membrane consists of expanded PTFE and is sold under the trade name GORE periodontal membrane [Gottlow et al. Clin. Pe riodontology 1984; 9: 494-503, Pontoriero R. J. et al. Clin. Periodontology 1988; 15: 247-254, Pontrylo R. J. et al. Clin. Periodontology 1989; 16: 170-174; Et al., 1986; 13: 604-616, Becker W. et al. Et al., Int. G. Periodont. Rest. Dent. 1988; 3: 2-16]. This technique, when modified, is said to be useful in connection with fixtures. A flat membrane is applied over the fixture, below the flap [Dahlin et al., Int. J. Oral Maxillofac. Implants 1989; 4 (1): 19-25, Becker W. Et al., Int. J. Periodont. Rest. Dent. 1990; 10: 93-102]. However, it has been found that this technique does not provide satisfactory regeneration of bone tissue. As described in the patent publication PCT / SE91 / 00216, a soft cell-tight membrane allows the fixture to continuously regenerate bone tissue, ie from the surrounding bone level (up). It has been found to be inappropriate for coronal regeneration. Instead, jaw cells, previously thought to be disadvantageous for bone tissue regeneration, have in fact proved to be very advantageous in this way. Therefore, bone cells from the periosteum and epiphysis should be able to reach the surgical area around the fixture. This accessibility can be caused by the rigidity and holes of the device according to this patent publication. This technology is described in The International Journal of Oral and Maxillofacial Implants (1995), Vol. S.1 It is also described in the literature by Jovanovic et al. According to this document, coronary bone formation is exemplified by membrane implantation treatment in a dog model. Bone formation has been obtained by using a reinforced e-PTFE membrane using titanium. These membranes retained their original morphology during the study, providing more room for clot stabilization and resulting in more bone than with standard membranes. It has now been found that replacing the net used in the literature by Jovanovic et al. With a fibrous material, preferably in the form of wool, provides a sufficiently stiff and space-giving ability. WO 9007308 describes a barrier which may be in the form of a fibrous material. This barrier is intended for the regeneration of bone-supporting tissue, and predictable healing, including firstly periodontal ligament tissue, secondly surrounding alveolar bone tissue, thirdly gingival connective tissue and epithelial regeneration It is said to give results. For example, it is essential to use a barrier in combination with a separating means including a ridge. It is further recommended that the barrier be made of a biodegradable material. In contrast to this known material, which gives special healing results of different cells, the fibrous material according to the invention mainly or essentially induces or regulates the regeneration or growth of only bone cells in the surgical intervention area It is intended to be used as a transplant tissue for the purpose. According to the patent WO 90007308, the kind of separating means required is unnecessary. Furthermore, according to the invention, the induced growth or regeneration of bone cells is determined by the shape and material of the implant and depends on the injury to be treated. In practice, the shape of the implant is determined by the person performing the surgery. The novel implant according to the present invention consists essentially of a porous, biocompatible, non-biodegradable (non-biodegradable) material that forms a three-dimensional space, the material comprising bone cells. It can be attached to it or modified so that the cells attach to it, in a form that allows the cells to grow three-dimensionally. It is essential that this material be fibrous, preferably in the form of wool. Particularly preferred forms are wool, thread or pad, which can be easily made by the surgeon to the desired shape. The novel material according to the invention should be strong enough to withstand the pressure prevailing in the region of the body into which it is inserted and have a suitable porosity. The actual diameter of the fiber will vary depending on the body part and the required strength. Usually this diameter is smaller than 1 mm, preferably smaller than 0.5 mm, most preferably 0. Less than 1 mm. Regarding porosity, it is clear that the higher the porosity, the more bone cells will form in the space of the implant. However, too high a porosity reduces the ability of the implant to withstand the pressure exerted by adjacent tissue. On the other hand, if a drilling operation has to be performed in the newly formed bone, for example to fix a screw, the porosity should not be too low. Thus, the optimal porosity depends on where the fiber material is used and can be easily determined by one skilled in the art. The novel biocompatible implant preferably comprises titanium or titanium-coated fibers. Preferably, the fibers are in the form of titanium wool. Another type of material is a ceramic material. In addition, the novel materials can be provided in the form of threads or pads, which are optionally at least partially provided by a film or membrane of polylactic acid, for example, to avoid inadvertent penetration of fibers through the mucous membrane. May be coated. Compared to the devices known from PCT / SE91 / 00216 and the above-mentioned document by Jabanovic et al., The device according to the invention offers several advantages. That is, the new device can be obtained in almost any form and can be more or less tailored to the intended use. The new material provides an increased surface for rapid bone regeneration, thereby increasing bone cell proliferation, as newly formed bone cells have been shown to have a tendency to bulge on surfaces. Another advantage is that the equipment can be made without the need for expensive manufacturing equipment. Another advantage relates to the ability to bind bone morphological proteins (BMPs) to the fibers according to the invention. The novel device is also useful in areas other than dental prostheses where there is a problem replacing skeletal parts that have lost their original configuration. After a traffic accident, crushed or depressed skeletal parts of the face must be repaired, and bone regeneration treatment requires surgical removal of skeletal parts that need to be replaced from time to time. The method using the transplanted tissue is described below. The area where the implant is to be implanted is first exposed by lifting one or two separate mucoperiosteal flaps. Drill fine holes (0.5-1 mm in diameter) in the bone tissue and drill holes in the dense bone wall to facilitate bleeding into the injured area. This technician improves the bone regeneration process in the area to be regenerated. The surgeon examines the area and selects the appropriate implant size. Thereafter, the implant is trimmed to conform to the defect morphology. If necessary, the implant is fixed to the bone. For example, this can be done differently with small screws. Trim the soft tissue and place it over the implant so that it is completely covered by the valve. The valve is sutured and the area is left to treat. During the treatment phase, the area should be protected against external forces. This means that if the implant is used in the mouth, it is better not to have removable dentures during the treatment phase.

Claims (1)

【特許請求の範囲】 1.本質的に非生物分解性である三次元空間を形成する多孔質生体適合性材料 から本質的になる新規な移植組織であって、骨細胞をそれに付着させることがで きる形態又はそれら細胞をそれに付着させるように変性し得る形態をしており、 しかも、主に骨細胞を三次元的に成長させることができ、本質的に繊維材料から なる、上記移植組織。 2.繊維材料がチタン又はチタン被覆繊維から本質的になる、請求項1記載の 移植組織。 3.少なくとも部分的に生体再吸収性膜により覆われている、請求項1記載の 移植組織。 4.チタンウールの糸又はパッドの形をしている請求項1〜3のいずれか1項 に記載の移植組織。 5.骨形態因子も含む、請求項1〜4のいずれか1項に記載の移植組織。 6.主に骨細胞を三次元的に成長させることができる移植組織の使用方法であ って、該移植組織は本質的に非生物分解性である三次元空間を形成する多孔質生 体適合性材料から本質的になり、しかも該移植組織は骨細胞をそれに付着させる 形態又はそれら細胞をそれに付着させ得るように変性させることができる形態を しており、本質的に繊維材料からなる、上記使用方法。 7.骨組織の選択的再生又は成長を与える方法において、骨組織を成長させる ための規定された場所は外科的介入により与え;本質的に非生物分解性である三 次元的空間を形成する多孔質生体適合性材料から本質的になる移植組織であって 、骨細胞をそれに付着させる形態又はそれら細胞をそれに付着させ得るように変 性することができる形態を有し、本質的に繊維材料からなる該移植組織を、選択 された移植領域に配置し;軟質組織をトリミングし、次いで、該軟質組織が縫合 後該移植組織を完全に覆うような仕方で、該軟質組織を該移植組織の上に置くこ とを特徴とする、上記方法。[Claims]   1. Porous biocompatible materials forming a three-dimensional space that is essentially non-biodegradable Is a new implant that consists essentially of In a form that can be denatured so that the cells can adhere to it, Moreover, bone cells can be grown mainly three-dimensionally, essentially from fiber material. The above transplant.   2. The fiber material of claim 1, wherein the fiber material consists essentially of titanium or titanium-coated fibers. Transplant tissue.   3. 2. The method of claim 1, wherein the bioresorbable membrane is at least partially covered by the bioresorbable membrane. Transplant tissue.   4. 4. A titanium wool thread or pad in the form of one of claims 1-3. 3. The transplanted tissue according to 1.   5. The transplant according to any one of claims 1 to 4, further comprising a bone morphological factor.   6. This is a method of using a transplant that can mainly grow bone cells three-dimensionally. Thus, the implant is a porous biomaterial that forms a three-dimensional space that is essentially non-biodegradable. Consists essentially of a biocompatible material, and the implant attaches the bone cells to it Morphology or morphology in which those cells can be denatured to allow them to attach to them The use as described above, wherein the method consists essentially of a fibrous material.   7. Growing bone tissue in a method for providing selective regeneration or growth of bone tissue A defined place for surgery is provided by surgical intervention; three that are essentially non-biodegradable An implant consisting essentially of a porous biocompatible material that forms a three-dimensional space In a form that allows bone cells to attach to it, or so that the cells can attach to it. The implant, which has a morphologically compatible form and consists essentially of a fibrous material, is selected The soft tissue is trimmed, and then the soft tissue is sutured. Thereafter, the soft tissue is placed over the implant in a manner that completely covers the implant. The above method, characterized in that:
JP53567198A 1997-02-14 1998-02-13 Bone graft Pending JP2001511677A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700514A SE9700514D0 (en) 1997-02-14 1997-02-14 Bone tissue regeneration device
SE9700514-4 1997-02-14
PCT/SE1998/000265 WO1998035628A1 (en) 1997-02-14 1998-02-13 Bone implant

Publications (1)

Publication Number Publication Date
JP2001511677A true JP2001511677A (en) 2001-08-14

Family

ID=20405788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53567198A Pending JP2001511677A (en) 1997-02-14 1998-02-13 Bone graft

Country Status (4)

Country Link
EP (1) EP1003437A1 (en)
JP (1) JP2001511677A (en)
SE (1) SE9700514D0 (en)
WO (1) WO1998035628A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008006276A (en) * 2006-05-30 2008-01-17 Hi-Lex Corporation Medical material and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA992255A (en) * 1971-01-25 1976-07-06 Cutter Laboratories Prosthesis for spinal repair
SE8804641D0 (en) * 1988-12-23 1988-12-23 Procordia Oratech Ab SURGICAL BARRIER
SE468339B (en) * 1990-03-21 1992-12-21 Stefan Renvert DEVICE FOR PROMOTING GROWTH OF BONE TAPE AND DEVICE FOR PROCEDURAL ANCHORING OF AN IMPLANT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008006276A (en) * 2006-05-30 2008-01-17 Hi-Lex Corporation Medical material and manufacturing method thereof

Also Published As

Publication number Publication date
EP1003437A1 (en) 2000-05-31
WO1998035628A1 (en) 1998-08-20
SE9700514D0 (en) 1997-02-14

Similar Documents

Publication Publication Date Title
Watzinger et al. Guided bone regeneration with titanium membranes: a clinical study
Zitzmann et al. Alveolar ridge augmentation with Bio-Oss: a histologic study in humans.
Schenk et al. Healing pattern of bone regeneration in membrane-protected defects: a histologic study in the canine mandible.
Poli et al. Alveolar ridge augmentation with titanium mesh. A retrospective clinical study
Rominger et al. The use of guided tissue regeneration to improve implant osseointegration
Jovanovic et al. Supracrestal bone formation around dental implants: an experimental dog study.
JP2905592B2 (en) Methods and articles for treating periodontal diseases and bone defects
US9433707B2 (en) Bone graft material containment structures
CA2327789C (en) Membrane with tissue-guiding surface corrugations
US5464439A (en) Flexible membranes produced from organic bone matrix for skeletal repair and reconstruction
US5919234A (en) Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
Tinti et al. Guided tissue regeneration in mucogingival surgery
US5769637A (en) Dental implant and alveolar process augmentation structures and method of installation
Tinti et al. Expanded polytetrafluoroethylene titanium‐reinforced membranes for regeneration of mucogingival recession defects. A 12‐case report
Ito et al. Effects of bioabsorbable and non‐resorbable barrier membranes on bone augmentation in rabbit calvaria
Schopper et al. Long-term results after guided bone regeneration with resorbable and microporous titanium membranes
Sisk et al. A light and electron microscopic comparison of osseointegration of six implant types
Kahnberg Bone grafting techniques for maxillary implants
Fontana et al. Freeze‐dried dura mater for guided tissue regeneration in post‐extraction dental implants: a clinical and histologic study
RU2469675C1 (en) Method of subantral bone augmentation for dental implantation in upper ridge atrophy
JP2001511677A (en) Bone graft
US20230210638A1 (en) Dental membrane
Boyne The use of particulate bone grafts as barriers eliminating the use of membranes in guided tissue regeneration
Gardella et al. Guided bone regeneration, autogenous bone graft: limits and indications
van Steenberghe et al. Clinical Procedures of Guided Bone Augmentation